GlassScriptPhysician profile
Brent A Hemelt
NPI 1811930274
$9,287.20
in general payments reported to CMS, 2019-2025
10 companies · $1,558 in 2025
The $1,558 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,172 · 2020: $1,520 · 2021: $1,444 · 2022: $46.16 · 2023: $1,463 · 2024: $83.77 · 2025: $1,558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,896 · Food and Beverage: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,896.00 |
| Food and Beverage | $208.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $4,360.00 | 2019-2021 | |
| Organon LLC | $4,339.87 | 2021-2025 | Nexplanon |
| Abbvie INC. | $273.38 | 2019-2023 | |
| Astellas Pharma US INC | $104.37 | 2023-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $65.22 | 2019-2022 | |
| Minerva Surgical, INC | $44.36 | 2019 | |
| Amgen INC. | $39.27 | 2019 | |
| Millicent US INC | $29.10 | 2023-2024 | Intrarosa, Femring |
| Alexion Pharmaceuticals, INC. | $16.12 | 2022 | |
| Evofem Biosciences, INC. | $15.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Hemelt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.